Toggle navigation Home Team Team Media Collaborations Sponsors Acknowledgements Project Background Design CRISPR/Cas9 Strategy Experiments Notebook Results Perspective Interlab Study Parts Parts Basic Parts Composite Parts Human Pratices Overview Societal Issues of CRISPR/Cas9 Responsible Research and Innovation GMO regulation Integrated Practices Engagement Model Attributions Safety Contents 1 Tuesday 2st August 1.1 Lab work 1.1.1 Visualization 1.1.1.1 DreamTaq PCR on DH5alp|pPS16_001, DH5alp|pPS16_002, DH5alp|pPS16_005, DH5alp|pPS16_009, DH5alp|pPS16_0010, DH5alp|pPS16_011, DH5alp|pPS16_012, DH5alp|pPS16_013, DH5alp|pPS16_014, DH5alp|pPS16_015 1.1.1.2 Sequencing of the gBlock 4.2 Tuesday 2st August Lab work Visualization DreamTaq PCR on DH5alp|pPS16_001, DH5alp|pPS16_002, DH5alp|pPS16_005, DH5alp|pPS16_009, DH5alp|pPS16_0010, DH5alp|pPS16_011, DH5alp|pPS16_012, DH5alp|pPS16_013, DH5alp|pPS16_014, DH5alp|pPS16_015 By Charlène, Mathilde, Laetitia, Caroline and Léa A Low fidelity PCR was carried out following the usual protocol and using the universal puc19 primers. 6 clones for each transformations were tested. Each clone was re-plated and put at 37°C. Each clone was also cultured in 3mL of LB and Ampicilin. Sequencing of the gBlock 4.2 By Caroline The PCR products obtain with Q5 on pPS16_008 were send to sequencing.
By Charlène, Mathilde, Laetitia, Caroline and Léa
A Low fidelity PCR was carried out following the usual protocol and using the universal puc19 primers. 6 clones for each transformations were tested.
Each clone was re-plated and put at 37°C.
Each clone was also cultured in 3mL of LB and Ampicilin.
By Caroline
The PCR products obtain with Q5 on pPS16_008 were send to sequencing.
